Bone Biologics Corp
NASDAQ:BBLG
Bone Biologics Corp
NASDAQ:BBLG
Price:
1.36
USD
-4.23%
Market Closed
Market Cap:
$2.4m
Balance Sheet
Balance Sheet Decomposition
Bone Biologics Corp
Bone Biologics Corp
Balance Sheet Decomposition is not available for
Bone Biologics Corp
Bone Biologics Corp
Balance Sheet
Bone Biologics Corp
Bone Biologics Corp
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
3
|
1
|
1
|
1
|
1
|
0
|
0
|
7
|
8
|
3
|
3
|
|
| Cash |
0
|
0
|
3
|
1
|
1
|
1
|
1
|
0
|
0
|
7
|
8
|
3
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
0
|
0
|
4
|
2
|
1
|
1
|
1
|
0
|
0
|
7
|
9
|
4
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
4
+4 144%
|
2
-59%
|
1
-55%
|
1
+14%
|
1
+30%
|
0
-97%
|
0
N/A
|
7
N/A
|
9
+27%
|
4
-56%
|
4
+3%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accrued Liabilities |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
9
|
0
|
12
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Current Liabilities |
5
|
6
|
4
|
2
|
2
|
1
|
10
|
1
|
14
|
0
|
3
|
1
|
0
|
|
| Long-Term Debt |
0
|
0
|
4
|
5
|
8
|
8
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
6
+22%
|
8
+32%
|
7
-4%
|
9
+25%
|
9
+1%
|
10
+5%
|
12
+23%
|
14
+15%
|
0
-99%
|
3
+2 450%
|
1
-67%
|
0
-55%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
8
|
12
|
26
|
52
|
59
|
64
|
67
|
69
|
70
|
72
|
81
|
85
|
|
| Additional Paid In Capital |
2
|
2
|
8
|
20
|
42
|
49
|
55
|
55
|
55
|
77
|
78
|
84
|
89
|
|
| Total Equity |
5
N/A
|
6
-20%
|
4
+34%
|
6
-54%
|
8
-47%
|
8
0%
|
9
-2%
|
12
-38%
|
14
-15%
|
7
N/A
|
6
-10%
|
3
-51%
|
3
+20%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
4
+4 144%
|
2
-59%
|
1
-55%
|
1
+14%
|
1
+30%
|
0
-97%
|
0
N/A
|
7
N/A
|
9
+27%
|
4
-56%
|
4
+3%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
